SEC Form 4 · accession 0001209191-16-151500
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jon M Foster
Officer — Group President
Period of report
Nov 17, 2016
Accepted (ET)
Nov 21, 2016 · 6:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 17, 2016 | M | 75,000 | $17.33 | A | 76,870 | D | |
| Common Stock | Nov 17, 2016 | M | 12,500 | $21.35 | A | 89,370 | D | |
| Common Stock | Nov 17, 2016 | M | 10,000 | $22.10 | A | 99,370 | D | |
| Common StockF1 | Nov 17, 2016 | S | 97,500 | $74.90 | D | 1,870 | D | |
| Common Stock | holding | — | — | — | 55,112 | I | By 2016 GRAT (Spouse, Trustee) |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $17.33 | Nov 17, 2016 | M | 37,500 | D | — | Nov 2, 2021 | Common Stock | 37,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $17.33 | Nov 17, 2016 | M | 37,500 | D | — | Nov 2, 2021 | Common Stock | 37,500 | 0 | D |
| Non-Qualified Stock Option (right to buy) | $21.35 | Nov 17, 2016 | M | 12,500 | D | Nov 2, 2012 | Nov 2, 2021 | Common Stock | 12,500 | 0 | D |
| Non-Qualified Stock Option (right to buy)F4 | $22.10 | Nov 17, 2016 | M | 10,000 | D | — | Nov 2, 2021 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.705 to $75.10, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The option vested in equal increments at the end of fiscal years 2012, 2013 and 2014 upon the achievement of certain annual EBITDA performance targets.
- F3The option vested in three equal annual installments beginning on November 2, 2013.
- F4The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets.